Particle.news

Download on the App Store

Rockets Face Guard Dilemma After VanVleet’s ACL Surgery Under Tight Cap Limits

Strict cap rules leave Houston weighing internal ball-handlers versus a pricey veteran guard.

Overview

  • Houston announced Fred VanVleet underwent successful surgery on his right ACL, and though a late-season return is not ruled out, he is expected to miss most of 2025-26.
  • Houston sits roughly $1.2–$1.25 million below the first apron, limiting immediate signings; several recent signees are not trade‑eligible until mid‑December and a Disabled Player Exception is unavailable at that cap level.
  • Trade scenarios floated by analysts range from Boston’s Derrick White as a headline target to lower-cost options like Payton Pritchard, with other proposals mentioning Jrue Holiday and even a mock deal for Tyrese Maxey.
  • Celtics executive Mike Zarren publicly said there has been nothing close to serious about trading White or Jaylen Brown, underscoring the likely price and difficulty of a Boston deal.
  • Internal pathways highlighted by commentators include larger on‑ball roles for Amen Thompson and minutes for Reed Sheppard and Aaron Holiday, with suggestions Houston could initiate more offense through Kevin Durant and Alperen Şengün while reassessing closer to December trade windows; VanVleet’s one‑plus‑one deal also gives him leverage over any trade, though Houston holds substantial draft capital for potential moves.